🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Acetaminophen (or equivalent)

Found 96 matching trials

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

PHASE3

The primary objective of the study is to compare sacituzumab tirumotecan co...

Status

Recruiting

Location

Mayo Clinic in Arizona - Phoenix ( Site 0147)

Start Date

2023-12-15

Trial ID

NCT06170788

Treatments Being Tested

Sacituzumab tirumotecan Pembrolizumab Supportive care measures

Allo HSCT Using RIC for Hematological Diseases

PHASE2

This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...

Status

Completed

Location

Masonic Cancer Center at University of Minnesota

Start Date

2017-03-09

Trial ID

NCT02661035

Treatments Being Tested

Allopurinol Fludarabine Cyclophosphamide ATG TBI Tacrolimus MMF Peripheral Blood Stem Cells Related or Unrelated Bone Marrow Cells

Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma

N/A

To provide elotuzumab treatment for single-patient use....

Status

No Longer Available

Location

Icahn School.of Medicine at Mount Sinai

Start Date

TBD

Trial ID

NCT02541643

Treatments Being Tested

Elotuzumab

Effects of Gum Chewing on Appetite and Digestion

One obvious property difference between energy-yielding beverages and solid...

Status

Completed

Location

Purdue University

Start Date

2010-02

Trial ID

NCT01070212

Treatments Being Tested

soft gum firm gum no gum

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

PHASE3

The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...

Status

Active Not Recruiting

Location

Kaiser Permanente - Oakland ( Site 0054)

Start Date

2024-06-11

Trial ID

NCT06305754

Treatments Being Tested

Sacituzumab tirumotecan Pemetrexed Carboplatin H1 Receptor Antagonist H2 Receptor Antagonist Acetaminophen (or equivalent)Dexamethasone (or equivalent)Steroid Mouthwash (dexamethasone or equivalent)

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

PHASE3

This study will compare how safe and effective sacituzumab tirumotecan is v...

Status

Active Not Recruiting

Location

Banner MD Anderson Cancer Center ( Site 0119)

Start Date

2024-05-03

Trial ID

NCT06356311

Treatments Being Tested

Sacituzumab tirumotecan Trifluridine-Tipiracil Irinotecan Paclitaxel Docetaxel Rescue medications Supportive care measures

Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

PHASE3

The incorporation of proteasome inhibitors and immunomodulatory drugs into ...

Status

Active Not Recruiting

Location

Saint Antoine Hospital - Hematology Department

Start Date

2019-07-25

Trial ID

NCT03836014

Treatments Being Tested

Daratumumab/Lenalidomide/Dexamethasone for 24 months Daratumumab/Lenalidomide/Dexamethasone until progression

Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

PHASE1

Transplant rejection occurs when a patient's body does not recognize the ne...

Status

Completed

Location

University of Wisconsin - Department of Medicine

Start Date

2003-11

Trial ID

NCT00078559

Treatments Being Tested

Alemtuzumab Sirolimus Tacrolimus Kidney transplant Methylprednisolone (or equivalent)Acetaminophen Diphenhydramine Trimethoprim (TMP)/Sulfa (Bactrim, Septra)Valgancyclovir Acyclovir Pentamidine Clotrimazole Nystatin

To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery

PHASE1

There is a marked and long-lasting improvement in glucose homeostasis that ...

Status

Completed

Location

Washington University School of Medicine

Start Date

2014-07

Trial ID

NCT02204813

Treatments Being Tested

Placebo Lo-Xenin Hi-Xenin Extra Hi-Xenin

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

PHASE3

Researchers are looking for new ways to treat people with endometrial cance...

Status

Active Not Recruiting

Location

USA Mitchell Cancer Institute ( Site 4142)

Start Date

2023-12-06

Trial ID

NCT06132958

Treatments Being Tested

Sacituzumab tirumotecan Doxorubicin Paclitaxel Nab-paclitaxel Rescue medications

Previous Next